Dopamine Agonist-Induced Impulse Control Disorders in Patients with Prolactinoma: A Cross-Sectional Multicenter Study

Dogansen S. C., Cikrikcili U., Oruk G., Kutbay N. O., Tanrikulu S., HEKİMSOY Z., ...Daha Fazla

Journal of Clinical Endocrinology and Metabolism, cilt.104, sa.7, ss.2527-2534, 2019 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 104 Sayı: 7
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1210/jc.2018-02202
  • Dergi Adı: Journal of Clinical Endocrinology and Metabolism
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2527-2534
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known. Objective: To evaluate the prevalence of DA-induced ICDs and possible risk factors related to these disorders in patients with prolactinoma. Design, Setting, and Participants: This is a cross-sectional multicenter study involving 308 patientswith prolactinoma followed up in tertiary referral centers who received at least three months of DA therapy. DA-induced ICDs (pathological gambling, hypersexuality, compulsive shopping, and compulsive eating) and impulsivity were assessed using the Questionnaire for Impulsive- Compulsive Disorders in Parkinson Disease and the Barratt Impulsiveness Scale-11, respectively. Patients were evaluated in terms of parameters related to ICD development.